GlaxoSmithKline to Pay Utah $8.5 Million to Settle Avandia Case

SALT LAKE CITY (AP) -- Utah will receive $8.5 million from a drugmaker accused of making misleading claims about a new drug for diabetes.

GlaxoSmithKline admitted no wrongdoing in agreeing to settle a lawsuit filed by the Utah Attorney General's Office.

The Utah Attorney General's Office alleged GlaxoSmithKline marketed Avandia nationwide as a "wonder drug" offering a "significant advance" in diabetes treatment, despite evidence it increases the risk of heart attacks for certain users.

Assistant Attorney General Robert Morton represented the state in the negotiations with help from private law firms.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2759817, ~/Articles/ArticleHandler.aspx, 4/16/2014 4:26:20 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...